产品封面图

TAK-778,180185-61-9

收藏
  • 询价
  • MedChemExpress(MCE)已认证
  • 美国
  • HY-100167
  • 2025年12月05日
    avatar
    品牌商
    14钻石会员
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 保存条件

      Please store the product under the recommended conditions in the Certificate of Analysis.

    • 库存

      货期:询盘

    • 供应商

      MedChemExpress LLC

    • 规格

      询盘

    MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。

    TAK-778

    CAS No. : 180185-61-9

    MCE 国际站:TAK-778

    产品活性:TAK-778 是依普黄酮的衍生物,已显示在体外和体内模型中能诱导骨生长。

    研究领域:Others

    作用靶点:Others

    In Vitro: TAK-778 is a derivative of ipriflavone and has been shown to induce bone growth in in vitro and in vivo models.Continuous treatment with TAK-778 (10 μM) for 1 to 21 days results in an increase in the area of mineralized nodules. TAK-778 at concentrations of 1 μM and higher significantly stimulates the activity of cellular Alkaline phosphatase (ALP). TAK-778 increases slightly but significantly the DNA content of the cells at the confluence stage. Treatment with TAK-778 also results in dose-dependent increases in the amount of soluble collagen and osteocalcin secreted into culture medium from days 5 to 7. TAK-778 enhances the secretion of both TGF-β and IGF-I at every time point during the 21 days of culture. Treatment of the cells with TAK-778 does not induce ALP activity, but does result in a dose-dependent increase in the saturated cell density. TAK-778 at a concentration of 10 μM significantly reduces the saturated cell density.

    In Vivo: Treatment with a single local application of TAK-778/PLGA-MC (0.2 to 5 mg/site) results in a dose-dependent increase in the radio-opaque area formed in the defect. Histological studies show the defect area is occupied by a bony bridge and the newly-formed radio-opaque area corresponds to a calcified bone containing bone marrow cavities surrounded by thick osteoid seams with cuboidal osteoblasts. There is no significant difference in either of the indices between placebo- or TAK-778/PLGA-MC-treated skulls. Two months after the operation, the TAK-778/PLGA-MC pellets induce radiological osseous union across the defects. Oral treatment of OVX rats with TAK-778 causes a more pronounced increase in bone mineral density (BMD) of the lumbar vertebrae compare to vehicle controls.

    相关产品:Digitonin  |  5-Ph-IAA  |  FLAG peptide  |  Tocofersolan  |  Monocrotaline  |  Lactate sodium  |  TCEP hydrochloride  |  3X FLAG peptide  |  DPPH  |  Pertussis Toxin  |  Pronase E (Activity ≥ 7000 U/g)  |  O-Propargyl-Puromycin  |  NMDI14  |  Phytohemagglutinin  |  MYLS22  |  Hyaluronidase  |  Biotinyl tyramide  |  Kifunensine  |  Human IgG1 kappa, Isotype Control  |  4-Azido-L-phenylalanine  |  6-Aminonicotinamide  |  Ammonium tetrathiomolybdate(VI)  |  OVA Peptide(257-264) TFA  |  Alkyne-phenol  |  Lauryl maltose neopentyl glycol  |  SHIN1  |  CHAPS  |  Cytosporone B

    热门产品线:重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

    Trending products:Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds

    类药多样性化合物库
    顾客使用MCE产品发表的科研文献
    一站式药筛新体验
    MCE 您身边的生物活性分子大师 | 抑制剂、激动剂、化合物库
    重组蛋白 | 高纯度、高稳定性
    磁珠
    MCE Hotline: 4008203792 | 中国现货 - 全球文献引用 - 高纯度高品质 - 全方位技术支持

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • 脑卒中的分布和危险因素

      354 287 60~ 886 875 794 618 600 622 65~ 839 1025 949 778

    • 【共享】慢病毒载体

      3RfMWaNSokZTDJCEuuCkxv9j61CAtyxOat3FhQ/JDCi1khyoFgJMy2pLNi6ijRfFAREZbYSshbE4KGxaWjoNKliqVrjPaduveHeIh4qfMmjEDp06eQumyZaS1ChrlK5THvj174xU+JKG2Y0cpt43IWVOKuHBhAhmFAB+7ZJSdzODrkAX+hvcfMo7Mph2aNlzB6xVxM1YuW4pDR4+iNQkFg8lzoWhRkxSdxY8fP1CmTGlpDHvybClTpkyKjpecnYvIp0I

    • 病例对照研究的优缺点

      1.5 1:1 9090 1927 1039 749 610 531 485 442 442 479 570 778 1:2 6758

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1500
    北京义翘神州科技股份有限公司(Sino Biological Inc.)
    2025年08月12日询价
    询价
    上海雅心生物技术有限公司
    2026年01月26日询价
    ¥2000
    上海冠东生物科技有限公司
    2026年01月02日询价
    ¥1350
    上海伟进生物科技有限公司
    2025年12月24日询价
    ¥320
    上海嵘崴达实业有限公司
    2025年08月25日询价
    TAK-778,180185-61-9
    询价